Secretary, Pharmaceuticals highlights India’s growth trajectory in medical technology sector at APAC MedTech Forum

Shri Amit Agrawal, Secretary of the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, presented India’s strategic vision to establish itself as a global leader in medical technology during his keynote address at the APACMed Medical Technology Forum (MTF) 2025 Leadership Dialogue on “Unlocking India for Global Leadership in MedTech.”

Highlighting India’s distinct demographic advantage, sustained economic growth, and conducive policy environment, Shri Agrawal stated that India is well-positioned to substantially increase its share in the global medical technology market by 2047. This expansion will be driven by the scaling up of public healthcare programmes, rising disposable incomes, and broader access to medical services, establishing India as one of the world’s most promising MedTech markets.

To complement innovation initiatives, three modern medical device parks are under construction and are expected to be operational by early 2027. These parks will offer shared infrastructure and specialized facilities for manufacturing critical raw materials and components such as medical-grade alloys, ceramics, polymers, glass, and packaging materials. This infrastructure development is aimed at reducing import reliance and enhancing ease of doing business for manufacturers.

Shri Agrawal highlighted initiatives to strengthen NIPER–industry collaboration, including creation of a NIPER Academia–Industry Coordination Committee, Industry–Institute Cells, industry representation on Boards of Studies, chair professorships and professors of practice, and local Industry–Institute Partnership Forums. He emphasised that these efforts aim to co-develop curricula, expand continuing education and industrial training, foster faculty and student engagement at industry sites, promote sponsored and joint research, and prioritise industry-oriented projects.

Reaffirming the success of the Production Linked Incentive (PLI) Scheme for medical devices, Shri Agrawal noted that it has already accelerated domestic manufacturing and attracted significant global investments. The government’s objective is to position India as an integral player across the entire global value chain—from innovation and design to manufacturing and exports.

Emphasizing India’s commitment to global cooperation, Shri Agrawal invoked the Indian philosophy of “Vasudhaiva Kutumbakam” — the world is one family — aligned with the theme of India’s G20 Presidency, “One Earth, One Family, One Future.” He stressed that India seeks to advance global healthcare through collaborative partnerships with nations worldwide.

The Ministry of Chemicals and Fertilizers remains committed to steering India’s emergence as a premier destination for MedTech innovation and manufacturing, supporting the nation’s vision of comprehensive self-reliance and active global engagement in health technology.